USP24 is an ISG15 cross-reactive deubiquitinase that mediates IFN-I production by de-ISGylating the RNA helicase MOV10

Rishov Mukhopadhyay, Simeon D Draganov, Jimmy J.L.L Akkermans, Marjolein Kikkert, Klaus-Peter Knobeloch, Günter Fritz, María Guzmán, Sonia Zuñiga, Robbert Q Kim, Benedikt M Kessler, Adán Pinto-Fernández, Paul P Geurink, Aysegul Sapmaz
{"title":"USP24 is an ISG15 cross-reactive deubiquitinase that mediates IFN-I production by de-ISGylating the RNA helicase MOV10","authors":"Rishov Mukhopadhyay, Simeon D Draganov, Jimmy J.L.L Akkermans, Marjolein Kikkert, Klaus-Peter Knobeloch, Günter Fritz, María Guzmán, Sonia Zuñiga, Robbert Q Kim, Benedikt M Kessler, Adán Pinto-Fernández, Paul P Geurink, Aysegul Sapmaz","doi":"10.1101/2024.09.06.611391","DOIUrl":null,"url":null,"abstract":"The interferon-stimulated gene 15 (ISG15) is a ubiquitin-like modifier induced by type I Interferon (IFN-I) and plays a crucial role in the innate immune response against viral infections. ISG15 is conjugated to target proteins by an enzymatic cascade through a process called ISGylation. While ubiquitin-specific protease 18 (USP18) is a well-defined deISGylase counteracting ISG15 conjugation, ISG15 cross-reactive deubiquitylating enzymes (DUBs) have also been reported. Our study reports USP24 as a novel ISG15 cross-reactive DUB identified through activity-based protein profiling (ABPP). We demonstrate that recombinant USP24 processed pro-ISG15 and ISG15-linked synthetic substrates in vitro. Moreover, the depletion of USP24 significantly increased the accumulation of ISG15 conjugates upon IFN-β stimulation. An extensive proteomic analysis of the USP24-dependent ISGylome, integrating total proteome, GG-peptidome, and ISG15 interactome data, identified the helicase Moloney leukemia virus 10 (MOV10) as a specific target of USP24 for deISGylation. Further validation in cells revealed that ISGylated MOV10 enhances IFN-β production/secretion, whereas USP24 deISGylates MOV10 to negatively regulate the innate immune response. This study showcases USP24's novel roles in modulating ISGylation and modulation of the IFN-I-dependent immune responses, with potential therapeutic implications in infectious diseases, cancer, autoimmunity, and neuroinflammation.","PeriodicalId":501147,"journal":{"name":"bioRxiv - Biochemistry","volume":"86 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv - Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.06.611391","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The interferon-stimulated gene 15 (ISG15) is a ubiquitin-like modifier induced by type I Interferon (IFN-I) and plays a crucial role in the innate immune response against viral infections. ISG15 is conjugated to target proteins by an enzymatic cascade through a process called ISGylation. While ubiquitin-specific protease 18 (USP18) is a well-defined deISGylase counteracting ISG15 conjugation, ISG15 cross-reactive deubiquitylating enzymes (DUBs) have also been reported. Our study reports USP24 as a novel ISG15 cross-reactive DUB identified through activity-based protein profiling (ABPP). We demonstrate that recombinant USP24 processed pro-ISG15 and ISG15-linked synthetic substrates in vitro. Moreover, the depletion of USP24 significantly increased the accumulation of ISG15 conjugates upon IFN-β stimulation. An extensive proteomic analysis of the USP24-dependent ISGylome, integrating total proteome, GG-peptidome, and ISG15 interactome data, identified the helicase Moloney leukemia virus 10 (MOV10) as a specific target of USP24 for deISGylation. Further validation in cells revealed that ISGylated MOV10 enhances IFN-β production/secretion, whereas USP24 deISGylates MOV10 to negatively regulate the innate immune response. This study showcases USP24's novel roles in modulating ISGylation and modulation of the IFN-I-dependent immune responses, with potential therapeutic implications in infectious diseases, cancer, autoimmunity, and neuroinflammation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
USP24 是一种 ISG15 交叉反应型去泛素化酶,它通过去 ISGyl 化 RNA 螺旋酶 MOV10 来介导 IFN-I 的产生。
干扰素刺激基因 15(ISG15)是一种由 I 型干扰素(IFN-I)诱导的泛素样修饰因子,在针对病毒感染的先天免疫反应中发挥着至关重要的作用。ISG15 通过一个称为 ISGylation 的酶级联过程与目标蛋白质结合。虽然泛素特异性蛋白酶 18(USP18)是一种定义明确的去 ISGyl 化酶,能抵消 ISG15 的共轭作用,但也有报道称 ISG15 交叉反应性去泛素化酶(DUB)。我们的研究报告了通过基于活性的蛋白质分析(ABPP)发现的新型 ISG15 交叉反应 DUB USP24。我们证明,重组 USP24 可在体外处理原 ISG15 和 ISG15 链接的合成底物。此外,在 IFN-β 刺激下,USP24 的耗竭会显著增加 ISG15 共轭物的积累。对依赖于 USP24 的 ISGylome 进行了广泛的蛋白质组分析,整合了总蛋白质组、GG-肽组和 ISG15 相互作用组数据,确定了螺旋酶 Moloney leukemia virus 10 (MOV10) 是 USP24 去 ISGyl 化的特异性靶标。在细胞中的进一步验证表明,ISGylated MOV10 能增强 IFN-β 的产生/分泌,而 USP24 则能使 MOV10 去 ISGyl 化,从而对先天性免疫反应产生负面调节作用。这项研究展示了 USP24 在调节 ISGylation 和调节 IFN-I 依赖性免疫反应方面的新作用,对传染病、癌症、自身免疫和神经炎症具有潜在的治疗意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems Molecular activity mediates the composition and assembly of dissolved organic matter in lake sediments Structural insights into terminal arabinosylation biosynthesis of the mycobacterial cell wall arabinan Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE Affinity tag free purification of SARS-Cov-2 N protein and its crystal structure in complex with ssDNA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1